Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Nodal and Distant Metastatic Disease Detected by PSMA PET in Treatment-Naïve High-Risk Prostate Cancer: A Czech Multicentre Cohort Study

NCT07608419 is registered in ClinicalTrials.gov with General University Hospital, Prague as lead sponsor.

NCT NCT07608419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07608419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Nodal and Distant Metastatic Disease Detected by PSMA PET in Treatment-Naïve High-Risk Prostate Cancer: A Czech Multicentre Cohort Study
Lead sponsor
General University Hospital, Prague
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2016
Completion date
December 31, 2027
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

high risk prostate cancer, prostate cancer, psma pet, staging